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Available online 14 March 2008Ventral enclosure in Caenorhabditis elegans involves migration of epidermal cells over a neuroblast substrate
and subsequent adhesion at the ventral midline. Organisation of the neuroblast layer by ephrins and their
receptors is essential for this migration.We show that bus-8, which encodes a predicted glycosyltransferase, is
essential for embryonic enclosure and acts in or with ephrin signalling tomediate neuroblast organisation and
to permit epidermal migration. BUS-8 acts non-cell-autonomously in this process, and likely modiﬁes an
extracellular regulator of ephrin signalling and cell organisation. Weak and cold-sensitive alleles of bus-8
show that the gene has a separate and distinct post-embryonic role, being essential for epidermal integrity
and production of the cuticle surface. This disorganisation of the epidermis and cuticle layers causes increased
drug sensitivity, which could aid the growing use of C. elegans in drug screening and chemical genomics. The
viable mutants are also resistant to infection by the pathogenMicrobacterium nematophilum, due to failure of
the bacterium to bind to the host surface. The two separate essential roles of BUS-8 in epidermal
morphogenesis add to our growing understanding of the widespread importance of glycobiology in
development.







The epidermis is the outer layer of an organism and functions as a
barrier between the external environment and the internal tissues. It is
an initial point of adhesion for pathogens, and epidermal integrity
must be maintained to prevent pathogen invasion. Epidermal devel-
opment is also important for the establishment of body morphology.
The epidermis in Caenorhabditis elegans (also called the hypodermis) is
a single layer of cells. It undergoes epiboly during embryogenesis,
migrating around the surface of the embryo tomeet on the ventral side
(Sulston et al.,1983). Ventral enclosure of the embryo by the epidermis
has been extensively studied and occurs in two steps (Williams-
Masson et al., 1997). Initially four anterior epidermal cells (the ‘leading
cells’) migrate around the embryo to the ventral midline, by extending
actin-rich ﬁlopodia. The more posterior epidermal cells (the ‘ventral
pocket cells’) followand complete enclosure of the embryo bymeeting
at the midline, after the leading cells. Once ventral enclosure is
completed, the embryo elongates to form a cylindrical worm (Priess
andHirsh,1986), and the epidermis is covered byan extracellular layer,
the cuticle (Sulston et al., 1983).l rights reserved.Ventral enclosure in C. elegans is a genetically tractable model for
several aspects of epithelial biology, including changes in cell shape,
cell migration, adhesion, and cell fusion (Chisholm and Hardin, 2005).
Several conserved molecules play important roles in these processes.
The ephrin-receptor (Eph) VAB-1 and the ephrins VAB-2 and EFN-4
are required to organise the underlying neuroblasts, permitting cor-
rect migration and connection of ventral epidermal cells (Chin-Sang
et al., 1999; Chin-Sang et al., 2002; George et al., 1998). The LAR-like
receptor phosphatase PTP-3 (Harrington et al., 2002), MAB-20 sema-
phorin (Roy et al., 2000) and syndecan-interacting protein KAL-1
(Hudson et al., 2006) exhibit synergistic involvement in this process. A
cadherin (HMR-1) and α-/β-catenin (HMP-1 and HMP-2) system is
required for sealing of the epithelial sheet by stabilising the initial
contact between the opposing leading cells at the ventral midline
(Costa et al., 1998; Raich et al., 1999). In addition, the Arp2/3 complex
is required for cell migration (Sawa et al., 2003). The completed epi-
dermis provides both a barrier against pathogen invasion, and a po-
tential target for pathogen recognition and attack.
C. elegans is growing in importance as a model host for studying
infection (Gravato-Nobre and Hodgkin, 2005; Mylonakis et al., 2007).
Several signalling pathways have been shown to mediate protective
responses by theworm (Couillault et al., 2004; Garsin et al., 2003; Kim
et al., 2002, 2004; Nicholas and Hodgkin, 2004; Troemel et al., 2006).
In addition, C. elegans has proved useful for identifying host factors
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for their toxins. Yersinia pestis forms a bioﬁlm over the surface of the
nematode head (Darby et al., 2002), and several C. elegans mutants
have been identiﬁed that prevent Yersinia colonisation (Darby et al.,
2007). Another pathogenesis model involves binding of Bacillus
thuringiensis crystal toxins to C. elegans intestinal cells, which causes
lethality. Cloning of several worm mutants in which the toxin was
unable to bind led to the deﬁnition of a glycolipid receptor for the Bt
toxin (Grifﬁtts et al., 2005, 2002).
A new means of investigating the nematode epidermis has been
provided by a screen for C. elegans mutants with alterations in their
interaction with the pathogen Microbacterium nematophilum (Gra-
vato-Nobre et al., 2005; Hodgkin et al., 2002). This showed that at least
18 genetic loci (the bacterially unswollen or bus genes) are required for
the bacterium to adhere to and infect C. elegans. One of these genes,
srf-3, has been cloned and encodes a nucleotide-sugar transporter
(Hoﬂich et al., 2004); another, bus-17, encodes a predicted galactosyl-
transferase (Yook and Hodgkin, 2007). Abnormal lectin binding and
increased cuticle fragility are evident in null mutants of both these
genes, indicating that they are required for forming a normal cuticle
surface and barrier.
A related gene, bus-8, is the subject of this paper. In contrast to srf-
3 and bus-17, for which null mutants are viable, we ﬁnd that bus-8 is
an essential gene for two distinct phases of nematode development.
We report the isolation, characterisation, and cloning of a series of
mutants in the gene bus-8. Whilst the weakest allele was originally
isolated on the basis of its resistance to infection toM. nematophilum,
we show here that BUS-8 plays a fundamental and crucial role in
epidermal morphogenesis throughout the development of the worm.
BUS-8 is ﬁrst required for ventral enclosure of the embryo. In the
absence of BUS-8, the neuronal cells and neuroblasts that lie under-
neath the migrating epidermal cells are disorganised. This either
prevents, or causes abnormalities in, the migration of the epidermal
cells onto the ventral surface, leading to rupture during elongation.
This phenotype is similar to that seen in Eph or ephrin mutants, and
we show genetically that BUS-8 acts with the Eph VAB-1 and ephrins
VAB-2 and EFN-4. bus-8 encodes a predicted glycosyltransferase,
related to mannosyltransferases involved in protein N-glycosylation.
Prior to elongation, BUS-8 is expressed in the neuroblasts underlying
the migrating epidermal cells, but we show that expression outside
these cells is sufﬁcient to rescue a bus-8 mutant, implying that BUS-8
regulates cell migration in a non-cell-autonomous manner. After
elongation, bus-8 is expressed in epidermal seam cells and is required
post-embryonically for epidermal organisation, molting and produc-
tion of a normal cuticle surface. The epidermal defects inweaker bus-8
mutants cause hypersensitivity to a broad range of drugs. This drug
sensitivity, in otherwise viable worms, means that weak bus-8 alleles
may be useful tools for small molecule screens in C. elegans.
Materials and methods
C. elegans genetics
C. eleganswas cultured as described (Sulston and Hodgkin, 1998). bus-8(e2698)was
isolated in an EthylMethane Sulphonate (EMS) screen formutants that were resistant to
infection byM. nematophilum (Gravato-Nobre et al., 2005). bus-8(lj22)was isolated in a
screen for mutants that were hypersensitive to nicotine (Kari Dickinson and W.S.,
unpublished). This mutationwas previously referred to as nic-1(lj22) (Geng et al., 2003).
Further bus-8 alleles (e2882, e2883, e2885, e2887, e2891, and e2892) were isolated in an
EMS screen for mutants that did not complement the Bus (Bacterially unswollen)
phenotype of e2698. A deletion allele, tm1410, was obtained from the National
Bioresource Project for the Nematode, Japan.
Cloning and analysis of bus-8
bus-8wasmapped to a region between lon-2 and unc-97 on the X chromosome, and
this region was further narrowed using single nucleotide polymorphism mapping
between wild type N2 (Bristol) and Hawaiian (CB4856) isolates (Wicks et al., 2002).
Cosmids covering this regionwere tested for complementation bymicroinjection (Mello
et al., 1991). Two overlapping cosmids, F55D1 and T23F2 were found to rescue bus-8(e2698).APCRproduct containing a single gene, T23F2.1, and 3 kb upstream could rescue
all alleles of bus-8. PCR products covering the gene T23F2.1 were ampliﬁed from each
allele and sequenced using standard methods.
Embryonic and larval microscopy
The strain jcIs1 IV; bus-8(tm1410)/dpy-8(e130) axIs36 X was used to analyse
embryogenesis in bus-8(null)mutants. jcIs1 is an integrated AJM-1∷GFP marker, which
highlights adherens junctions in epithelial cells (Koppen et al., 2002). axIs36, a gift from
G. Seydoux, is an integrated pes-10∷gfp. This is expressed in most cells during em-
bryogenesis from the 28-cell stage, and there is no maternal contribution (Seydoux and
Fire, 1994). bus-8(tm1410) homozygotes could therefore be identiﬁed from the absence
of PES-10∷GFP expression. Embryos were dissected from gravid hermaphrodites in egg
buffer (118 mM NaCl, 40 mM KCl, 3 mM CaCl2, 3 mM MgCl2, 5 mM HEPES pH 7.2) and
mounted onto agarose pads (Sulston and Hodgkin, 1998). The coverslip was sealed with
immersion oil (Zeiss). Larvae or adults were anaesthetised in 1% 1-phenoxypropan-2-ol
in M9 buffer, and mounted onto agarose pads. Specimens were observed using a Zeiss
Axioplan 2 Imaging microscope.
Analysis of BUS-8 expression
A GFP reporter construct was made by cloning the complete bus-8 coding region,
plus 3 kb upstream, into a vector containing a GFP in an artiﬁcial operon (Coates and de
Bono, 2002). Tissue-speciﬁc expression constructs were made by amplifying the bus-8
coding region from genomic DNA and cloning it behind either unc-119 or ajm-1
promoters. Transgenic lines in this study were made by microinjection (Mello et al.,
1991) with the construct of interest injected at typically 10–20 ng/μl.
Ephrin interactions and mutagenesis
To assess potential genetic interactions, lethality was measured by picking L4 her-
maphrodites to individual plates, followed by sequential transfer to new plates every 12
or 24 h. The number of eggs laid, the number of dead embryos (N48 h after laying), and
the number of dead or arrested larvae were counted.
To test if the candidate vab-2 glycosylation site was required for functionality, the
region that is sufﬁcient to rescue VAB-2 (Chin-Sang et al., 1999) was ampliﬁed by PCR
from N2 genomic DNA and cloned into pCR II-TOPO (Invitrogen). Asparagine-31 (AAC)
was mutated to glutamine (CAA) by PCR fusion site-directed mutagenesis. WT and
mutant constructs were transformed into vab-2(e96)with sur-5p∷GFP as a transforma-
tionmarker (Gu et al., 1998). Hermaphrodites were dissected andmounted as described
before, incubated for 24 h at 22.5 °C, and the GFP positive progeny scored as Emb, Vab
(L1) or wild-type (L1).
Drug sensitivity and Hoechst staining
Sensitivity to drugs was assayed by picking gravid hermaphrodites into 96-well
plate wells containing the compound, and measuring the time until paralysis. Nicotine
was 0.1% v/v in M9. 1-Phenoxypropan-2-ol was 0.1% or 0.5% v/v in M9. Ivermectin was
dissolved in DMSO and diluted to 2.5 μg/ml in M9. Hoechst 33258 staining was as
described (Moribe et al., 2004).
Electron microscopy
Animals were ﬁxed in HEPES/sucrose buffer (0.1 M HEPES, 0.12 M sucrose, 0.05 M
MgCl2, pH 7.2) with 2.5% (v/v) glutaraldehyde by microwave ﬁxation and embedded in
agarose blocks. The blocks were dehydrated through an ethanol series before
embedding in Unicryl resin (BBInternational) by polymerisation at 60 °C. Ultrathin
sections (70 nm) were collected on formvar coated nickel grids and stained with uranyl
acetate and lead citrate before examination by transmission electron microscopy.Results
bus-8 mutants are defective in epidermal morphogenesis
Screens for mutants of C. elegans that are resistant to infection by
the pathogen M. nematophilum are easily carried out and yield many
mutants with demonstrable alterations to the cuticle surface. Multiple
mutations in many genes of this type (srf and bus genes) were
recovered in such a screen, but for one gene, designated bus-8, only a
single allele was recovered (Gravato-Nobre et al., 2005). The under-
representation of bus-8 alleles in the screen indicated that bus-8might
perform a more fundamental role in the development of C. elegans. To
examine this possibility, we used a non-complementation screen to
isolate further EMS alleles of bus-8. Five alleles, plus one further allele
isolated byW.S. (see Materials and methods), showed a range of post-
embryonic phenotypes (discussed later, and see Supplementary Table
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arrest during embryogenesis. A deletion allele (see cloning section),
tm1410, was obtained from the National Bioresource Project for the
Nematode, Japan. This shows a similar phenotype to e2892 and was
used for further analysis.
To understand the role of bus-8 in embryogenesis, we used time-
lapse microscopy (Figs. 1A–E). In wild type embryos, the epidermis
(also known as the hypodermis) begins as a set of cells of the dorsal
side of the embryo, which form a sheet and migrate to enclose the
ventral surface (Williams-Masson et al., 1997). Once ventral enclosure
is completed, contractions within the epidermis lead to elongation of
the embryo from a ball of cells into a cylindrical shaped worm (Priess
and Hirsh, 1986). In bus-8(tm1410) embryos, we were able to
distinguish three phenotypic classes (Figs. 1C–E, Table 1). In each,
cells escape from the interior of the embryo as it ruptures during
elongation. This is reminiscent of the defect seenwhen epidermal cells
are laser ablated prior to elongation (Priess andHirsh,1986), where the
pressure generated during elongation leads to extrusion of the
contents through gaps in the epidermal sheet. We therefore sought
to analyse ventral enclosure and related processes in bus-8(tm1410).
We examined embryos with an AJM-1∷GFP marker (Fig. 2), which
localises to the apical junctions of C. elegans epithelia basal to theFig. 1. (A) Cartoon showing some cell movements during ventral enclosure and elongation. P
layer of migrating epidermal cells (yellow/orange) * indicates the leading cells which make th
and dorsal surfaces (intercalating dorsal epidermal cells, blue) occurs by separate processes.
ventral enclosure and elongation. Scale bars indicate 20 μm. Arrows indicate cells that escape
an enlarged gastrulation cleft (*) which prevents epidermal cell migration. In class II embryos
to rupture along the anterior third of the ventral surface. In class III embryos, (E), epidermal en
tip of the embryo.cadherin–catenin complex, so visualising themigration and adherence
of the epidermal cells (Koppen et al., 2002).
bus-8 is required for organisation of the underlying neuronal substrate
and hence for epidermal migration
During ventral enclosure, the epidermal cells migrate over a layer
of neurons and neuroblasts. This layer of cells is organised during
closure of the ventral gastrulation cleft (George et al., 1998). In class I
bus-8(tm1410) embryos (the majority class, ca. 55%), the gastrulation
cleft was enlarged, deeper than normal, and persistent (Fig. 1C). The
migrating epidermal cells reached the lateral midline, but could not
migrate over the disorganised substrate. Only the most posterior
ventral pocket cells reached the ventral side (Fig. 2C), and the seam
cells retracted back to the dorsal surface (Fig. 2D). Once elongation
commenced, the embryo contents leaked through the unenclosed
ventral side.
In about 12% of embryos (class II), the gastrulation cleft was able to
close, and ventral enclosure was completed at the posterior, but not at
the anterior, causing rupture along the ventral midline along the
anterior third of the embryo as elongation commenced (Fig. 1D). AJM-
1∷GFP showed that the leading pairs of cells, which initiate migration,artially redrawn from Ghenea et al. (2005). Ventral neuroblasts (pink) are enclosed by a
e initial migration during ventral enclosure. Enclosure on the lateral (seam cells, green)
(B–E) Sequences of images from (B) wild type and (C–E) bus-8(tm1410) embryos during
from the interior of the embryo as it ruptures during elongation. (C) Class I embryos have
, (D), epidermal enclosure is normal at the posterior but defective at the anterior, leading
closure is grossly normal but during elongation there is a slow rupture from the anterior
Table 1
Frequency of embryogenesis defect phenotypes in bus-8(tm1410) and control embryos
Parental genotype pes-10∷gfp Inferred embryo
genotype
Arrest during embryogenesis WT: reach 3-fold ok
Class I: ventral
enclosure failure

















55% (18) 12% (4) 33% (11) 0% (0)




0% (0) 0% (0) 0% (0) 100% (20)
Rare lethality in the pes-10∷gfp positive embryos likely reﬂects recombination between tm1410 and axIs36, as 100% of jcIs1; dpy-8 axIs36 embryos develop normally under our
conditions.
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and could not form a stable adhesion junction. In contrast, the ventral
pocket cells completed migration and adhered normally, leading to an
embryo which was fully enclosed at the posterior but not enclosed at
the anterior of the ventral surface (Fig. 2F).
bus-8 is required for integrity of enclosure of the anterior of the head
In the weakest phenotype shown by bus-8(tm1410) embryos, class
III (about 33%), ventral enclosure was apparently normal, but as elo-
ngation progressed there was a slow leakage of cells from the anterior
tip of the animal, again resulting in lethal arrest (Fig. 1E). This is ap-
parently separate from a defect in ventral enclosure, as both the
leading cells and the ventral pocket cells migrate normally (Fig. 2G).
Rather this is an abnormality in the specialised epidermal cells,
hyp1–5. These cells form rings that enclose the anterior of the head,
and connect via the arcade cells to the pharyngeal epithelium
(Altun and Hall, 2006; Chisholm and Horvitz, 1995; Sulston et al.,
1983).
BUS-8 is a putative glycosyltransferase
We mapped bus-8 to a region on the X chromosome using a com-
bination of visible marker- and SNP-mapping (Gravato-Nobre et al.,
2005; Wicks et al., 2002). Transformation with a PCR product con-
taining a single open reading frame, T23F2.1, plus 3 kb upstream was
sufﬁcient to rescue the embryonic defects of both tm1410 and e2892;
and the post-embryonic defects of the other alleles. The rescue shows
that the embryonic lethality results from loss of this gene alone,
rather than from any linked mutations, a consideration that is rele-
vant because RNAi experiments on T23F2.1 have failed to detect em-
bryonic lethality (Kamath et al., 2003, Simmer et al., 2003, Frand
et al., 2005)
Moreover, we sequenced this gene from each of the alleles and
found mutations in all, with lesions roughly consistent with their
relative phenotypic severity (see Fig. 3). bus-8(tm1410) deletes much
of the coding region and causes a frame shift so is likely to be a null
allele. T23F2.1 encodes a putative glycosyltransferase, and has pre-
viously been described as the single C. elegans ortholog of the Sac-
charomyces cerevisiae gene ALG2 (Schachter, 2004). This encodes a
dual functional α-1,3- and α-1,6-mannosyltransferase, required for N-
linked protein glycosylation (Jackson et al., 1993; O'Reilly et al., 2006).
We reconstructed the phylogeny of BUS-8 related proteins and found
that, although bus-8 is closely related to ALG2 and ALG11 (which
encodes an α-1,2-mannosyltransferase also involved in N-glycosyla-
tion), there are two ALG2 homologs in C. elegans and other nematodes,
bus-8 and F09E5.2, due to a gene duplication event within or close to
the Nematoda (Supplementary Fig. S1). Of these two genes, F09E5.2 is
more similar to ALG2. BUS-8-like enzymes may remain involved in N-glycosylation, perhaps with different sugar or receiver substrates, but
the possibility that the function of BUS-8 has diverged away from N-
glycosylation remains open.
BUS-8 is expressed in two temporally- and spatially-distinct phases
To analyse the expression of BUS-8, we created a construct con-
taining the bus-8 promoter and complete genomic coding region
fused to GFP contained in an artiﬁcial operon. This construct drives
expression of GFP in the same cells as, but separate from, full-length
BUS-8; and was able to fully rescue bus-8(tm1410). During ventral
enclosure BUS-8 is not expressed in the migrating epidermal cells but
rather expressed weakly in cells underlying the migrating cells (Fig.
4A), which are likely to be neuronal (Chin-Sang et al., 2002). These
underlying cells include the ventral neuroblasts which are frequently
disorganised in bus-8(null) embryos. From the three-fold stage on-
wards however, the expression of BUS-8 switches to the seam cells, a
set of specialised epidermal cells on the lateral surfaces of the worm
(Fig. 4B). Expression continues to be restricted to these cells through
post-embryonic development (Fig. 4C).
BUS-8 acts in or with ephrin signalling to mediate neuroblast
organisation and epidermal migration
The defects in ventral neuroblast organisation and subsequent en-
closure in bus-8(tm1410) embryos are strikingly similar to those seen
in mutants in the C. elegans Eph and ephrins (Chin-Sang et al., 1999;
George et al., 1998; Wang et al., 1999). We therefore investigated
whether BUS-8 might act in ephrin signalling.
Genetic epistasis analysis can be used to determine whether genes
are involved in the same pathway. Perhaps the most commonly used,
and conceptually simplest, experiment involves making a double
mutant with null alleles of a pair of genes: if they act in the same
pathway there will be no increase in phenotypic severity (Huang and
Sternberg, 2005). However this type of experiment may not be
appropriate for genes which have multiple functions, as even if two
genes act in the same pathway, the other functions of one or both
genes may cause an increase in severity of the double mutants, hence
confusing the interpretation of the epistasis test. This consideration is
particularly relevant in the case of enzymes, which may have multiple
functions reﬂecting numerous substrates. Indeed this is true for BUS-
8, which clearly has Eph-independent roles, as its loss is completely
embryonic lethal, unlike that of VAB-1.
We therefore used a related genetic epistasis test that considers
the interaction between hypomorphic alleles of two genes. If the two
genes act in different pathways, then the double mutant will show (at
most) additive severity. However if the genes act (at least for some of
their functions) in the same pathway, there may be a supra-additive
synergism. Whilst this type of epistasis test is used less often in
Fig. 2. Epidermal cell movements visualised with AJM-1∷GFP in (A,B) wild type and (C–
G) bus-8(tm1410) embryos. (A) In wild type embryos, epidermal cells migrate over the
ventral surface and meet at the midline. (B) Lateral view showing the epidermal cells
completely enclose the worm as elongation commences. (C) In class I embryos, the
epidermal cells cannot migrate over the disorganised ventral surface, although ventral
pocket closure still occurs at the most posterior. (D) Following the failure of ventral
enclosure, the seam cells retract to the dorsal surface. (E) In class II embryos the leading
cells (*) show defects in migration. Despite this, the posterior pocket cells still meet at
the midline. (F) The anterior part of the ventral surface is unenclosed (dotted line). Once
elongation commences, cells escape though this region (arrow). (G) In class III embryos
ventral enclosure is normal, but during elongation cells escape from the anterior tip of
the embryo (arrow).
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has been formalised in the ﬁelds of population genetics and complex
trait genetics (Frankel and Schork, 1996).Fig. 3. Schematic depiction of the bus-8 genomic region, showing the nature and position of t
of 677 base pairs, causing a frame shift, and is likely to be a null allele. lj22 is a single nucleotid
coding region to the 5′, adding an expected transmembrane domain, but requires a translat
gene model, lj22 is a missense mutation (arginine to cysteine).We therefore looked for a genetic interaction between a tempera-
ture-sensitive weak allele of bus-8, e2887, and hypomorphic alleles of
the genes encoding the Eph VAB-1 (e2) and the two major ephrins
VAB-2 (e141) and EFN-4 (e660). In each case, at 15 °C, we saw subs-
tantially greater than additive synergistic embryonic lethality (Fig. 5).
Further evidence that bus-8 acts speciﬁcally in the Eph/ephrin genetic
pathway is that the bus-8 hypomorph enhanced the severity of both
the vab-2 and the efn-4 hypomorph to greater than that of the vab-2
and efn-4 null alleles respectively. This reﬂects the redundancy bet-
ween vab-2 and efn-4 (Chin-Sang et al., 2002). Since we propose that
BUS-8 is important for both VAB-2 and EFN-4-mediated Eph sig-
nalling, interfering with both via the bus-8 hypomorph allows the
observation of a greater than null synergism with each ephrin hypo-
morph. We conclude that one function of bus-8 is to act in or with
ephrin signalling, and hence that glycosylation of one or more of the
components of the ephrin signalling pathway may be essential. In
these experiments we are examining a complex biological outcome
rather than a simple biochemical pathway, but the observations are
sufﬁciently suggestive to lead us to investigate possible glycosylation
of ephrin signalling components.
Tetramerisation site glycosylation of ephrins is not required for
Eph-mediated embryonic morphogenesis
Several lines of evidence have led structural biologists to propose
that ephrin glycosylation is important for Eph/ephrin oligomerisation,
which is essential for signalling (Davis et al., 1994; Himanen and
Nikolov, 2003). Firstly, the EphB2 ligand binding-domain belongs to
SCOP fold superfamily 49785 (galactose-binding domain-like), which
almost exclusively contains lectins (Himanen et al., 1998; Murzin et al.,
1995). Secondly, an N-glycosylation site found in all but one of the
human ephrins, and in the C. elegans ephrins VAB-2 and EFN-4, lies at
the low afﬁnity tetramerisation interface in the EphB2-ephrin B2
crystal structure (Himanen et al., 2002), apparently positioned for the
glycan to interact with the Eph (Supplementary Fig. S2A,B). We tested
the hypothesis that this glycosylation site is important in vivo by using
site-directed mutagenesis to mutate the conserved asparagine to
glutamine in VAB-2. However VAB-2(N31Q) was able to rescue a vab-2
(e96) mutant with almost wild-type efﬁciency (Supplementary Fig.
S2C). With respect to EFN-4, it is unlikely that its glycosylation could
be the sole embryonic function of BUS-8 as EFN-4 is dispensible in all
but 14% of embryos (Chin-Sang et al., 2002) and ephrin-related arrest
phenotypes (class I and II) are found in about 65% of bus-8(tm1410)
embryos (Table 1). Another possibility is that, because C. elegans has
several ephrins, which may act together in the same ephrin-Eph clus-
ters, when VAB-2 is not glycosylated glycosylation of other ephrins is
sufﬁcient to stabilise the oligomers and permit Eph signalling. We
tested this by analysing whether VAB-2(N31Q) could rescue a vab-2
(null) efn-4(null) double mutant. In this experiment, the most import-
ant ephrin molecules are absent or not glycosylated at the conserved
site, as EFN-2 and EFN-3 do not play a major role during embryogen-
esis (Chin-Sang et al., 2002; Wang et al., 1999). However, again, VAB-2hemutations for each allele. Shading indicates untranslated regions. tm1410 is a deletion
e substitution in theWormbase predicted 5′UTR. An alternative genemodel extends the
ional frameshift for continuity of the open reading frame (F.P., J.H. unpublished). In this
Fig. 4. Expression of BUS-8: (A) lateral view of an embryo at the end of ventral enclosure. BUS-8 is expressed in cells underlying the epidermis, but not in the ventral epidermal cells
(*). (B) Lateral view of a three-fold embryo. (C) A L3 hermaphrodite. Scale bars indicate 50 μm.
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(Supplementary Fig. S2D).
It is therefore unlikely that BUS-8 plays a direct role in Eph sig-
nalling by glycosylating ephrins at the tetramerisation interface, and if
this ephrin glycosylation does promote oligomerisation it is not
essential in vivo.
BUS-8 acts non-cell-autonomously to organise the ventral neuroblasts
As described above, during ventral enclosure BUS-8 is not ex-
pressed in the migrating epidermal cells but rather in the underlying
neuronal cells. This would be consistent with a role in ephrin signal-
ling, because mutants of the VAB-2 ephrin can be rescued by expres-
sion of vab-2(+) driven by a neuronal promoter (unc-119p) but not by
an epithelial promoter (ajm-1p), which suggests that VAB-2 is re-
quired in the neuronal cells rather than the epidermal cells migrating
over them (Chin-Sang et al., 1999). We therefore tested corresponding
constructs in which wild-type BUS-8 was driven by either the
epithelial cell-speciﬁc promoter ajm-1p or by the nervous system
promoter unc-119p (Fig. 6A). Surprisingly, either construct was able to
rescue the embryonic lethality of bus-8(tm1410).
The interpretation of these experiments is dependent on assuming
that there is no “leaky” low-level misexpression from the apparently
tissue-speciﬁc promoters. Unfortunately, both the ventral neuroblastsFig. 5. Interaction of bus-8 with the Eph vab-1 and the ephrin genes vab-2 and efn-4 — at 15and migrating epidermal cells derive from the same progenitors
multiple times in the lineage of embryonic development so mosaic
analysis is not possible (Sulston et al., 1983). However, the results with
vab-2 (Chin-Sang et al., 1999) support the speciﬁcity of expression, and
under our conditions ajm-1p∷GFP and unc-119p∷GFP showed robust
and consistent expression in the expected tissues at the relevant
embryonic stages, with no detectable overlap (data not shown).
Furthermore this experiment is internally controlled for speciﬁcity of
expression because, as will be discussed later, neuronally expressed
bus-8 was not sufﬁcient to rescue the post-embryonic defects of
bus-8 mutants (Figs. 6B, C). BUS-8 therefore appears to act non-cell
autonomously both to organise the ventral neuroblasts and to permit
epidermal migration. One possibility is that BUS-8, directly or
indirectly, modiﬁes the extracellular matrix to regulate cell move-
ments and organisation.
Weaker alleles demonstrate a distinct post-embryonic requirement for
BUS-8
We have isolated several weaker mutations in bus-8, which do not
cause complete embryonic lethality, but rather reveal a post-
embryonic role for BUS-8 (Supplementary Table S1). Of these, two
alleles, e2887 and e2891 are cold-sensitive lethal, with limited
embryonic lethality (Fig. 5), but complete larval arrest of post-°C there is synergistic embryonic lethality between weak alleles of each pair of genes.
Fig. 6. Tissue-speciﬁc expression of bus-8: sufﬁciency during (A) embryogenesis and
post-embryonically for (B) bacterial susceptibility and (C) normal sensitivity to 1-
phenoxypropan-2-ol. In each case bus-8 is expressed epidermally (via the ajm-1
promoter), neuronally (via the unc-119 promoter) or under its endogenous promoter.
Larvae or embryos carrying each array were for (A) identiﬁed by PCR, and in (B) and (C)
by observation of the co-injected GFP marker.
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that this inviability is caused by defects during embryonic develop-
ment that are sufﬁciently mild to allow completion of embryogenesis,
but then result in death during larval development. To examine this
possibility, we took advantage of the cold sensitivity of e2887. EvenFig. 7. Temperature shift experiment with the cold sensitive allele e2887 shows that bus-8 h
(15 °C) or permissive temperature (22.5 °C) for embryonic and larval stages as indicated. Emwhen embryogenesis took place at the permissive temperature
(22.5 °C), temperature shift to 15 °C for larval development was
sufﬁcient to cause inviability (Fig. 7). This demonstrates that BUS-8
has a separate but essential post-embryonic role in development.
Weaker bus-8 mutants are viable but multi-drug sensitive
One allele, lj22, was originally isolated on the basis of its
hypersensitivity to nicotine. We measured the response of the viable
bus-8 alleles to a panel of drugs. These mutants, particularly e2887,
show strongly enhanced sensitivity to drugs of a variety of sizes and
structures (Figs. 8A–C). Partial loss-of-function bus-8 mutants are
multi-drug sensitive, indicating increased permeability rather than a
speciﬁc modulatory effect on drug action. To test this we used Hoechst
33258 staining (Moribe et al., 2004) to demonstrate increased
permeability directly. bus-8 mutants show increased uptake of the
dye (Figs. 8D, E).
BUS-8 is required post-embryonically for epidermal and cuticle integrity
The major route for absorption of anthelmintics by nematodes is
across the cuticle and hypodermis (Ho et al., 1992, 1994). In order to
investigate the increased permeability of bus-8 mutants, we used
electron microscopy to analyse the structures of these tissues (Figs.
9A, B). In bus-8(e2887), the epidermal cell layer between the cuticle
and body wall muscle is disordered, vacuolated, and much wider than
in wild-type. As visualised by electron microscopy, this epidermal
defect is somewhat similar to that seen when tsp-15,which encodes a
tetraspanin, is mutated (Moribe et al., 2004). This mutant also shows
increased permeability to Hoechst 33258. However bus-8 mutants
lack the cuticle disorganisation and blistering seen in tsp-15 mutants.
In wild-type animals, electron dense structures in the epidermis
known as ﬁbrous organelles link the body wall muscle to the cuticle
and are important for translating the force of muscle contraction into
locomotion (Francis and Waterston, 1991). These are apparently
disordered in bus-8(e2887). In contrast the cuticle is grossly normal
(Fig. 9B). However, the alleles e2887 (at the permissive temperature)
and e2882 show signiﬁcant larval lethality, particularly during
molting, the process where the cuticle is shed and reformed (data
not shown). T23F2.1/bus-8 was also recently identiﬁed in a genome-
wide RNA interference screen for genes involved in molting (Frand et
al., 2005), and larval lethality and molting defects (but not the
embryonic phenotypes we described previously) were also observed
in a general genome-wide RNA intereference screen (Kamath et al.,
2003). We also seemolting defects, such as body restriction points due
to incomplete cuticle shedding (Fig. 9C).
Infection, surfaces and movement
The ﬁrst allele of bus-8 was isolated based on its resistance to
infection by M. nematophilum. We have previously shown that this
resistance is due to a failure of the bacterium to adhere to the cuticle
surface of the mutant worm, and furthermore that the mutant surface
ectopically binds various lectins (Gravato-Nobre et al., 2005). Givenas distinct essential embryonic and post-embryonic roles. Growth was at the restrictive
b: embryonic lethality; Lvl: larval lethality; Lva: arrest during larval stages.
Fig. 8. bus-8 alleles are hypersensitive to a range of drugs due to increased permeability. (A–C) Sensitivity to (A) nicotine; (B) 1-phenoxypropan-2-ol; (C) ivermectin. (D,E)
Permeability to the dye Hoechst 33258 of (D) wild type and (E) bus-8(e2887).
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nematophilum adhesion (Hoﬂich et al., 2004), it seems likely that the
bacterium binds to a surface-exposed glycan epitope in the cuticle. It
however is possible that a BUS-8 dependent glycan molecule is
required for the production or surface exposure of a non-glycan
receptor. From the three-fold stage of embryogenesis and throughout
larval development, BUS-8 is expressed in the seam cells (Figs. 4B, C).
These are specialised epidermal cells that have an important role in
cuticle production and molting (Singh and Sulston, 1978). ExpressionFig. 9. Transmission electronmicrographs of the outer layers of (A) wild type and (B) bus-8(e2
organelles. Scale bar shows 500 nm. (C) Molting defect seen in bus-8(e2887). Scale bar ind
movement across the bacterial lawn. Scale bar indicates 1 mm.in these cells is therefore consistent with a direct role of BUS-8 in
producing the glycan receptor for M. nematophilum.
Further evidence for the altered surface properties of the viable
bus-8 mutants is their skiddy Uncoordinated movement (Figs. 9D,
E), where the worm appears to make normal muscle contractions, but
to lose traction over the bacterial lawn surface. This defect is found in
several of the M. nematophilum adhesion-defective bus mutants
(Gravato-Nobre et al., 2005; Yook and Hodgkin, 2007), and also, to a
lesser extent, in some of the surface antigenicity abnormal or srf887)worms. Labels: c, cuticle; e, epidermis; b, body wall muscle. Arrows indicate ﬁbrous
icates 20 μm. (D) Wild-type movement and (E) in bus-8(e2882) skiddy uncoordinated
557F.A. Partridge et al. / Developmental Biology 317 (2008) 549–559mutants, whichwere isolated based on their altered surface binding of
lectins and antibodies (Politz et al., 1990).
In contrast to the embryonic requirement for BUS-8 in either
neuronal or epidermal cells, BUS-8 expression in the epidermis, but
not in neuronal cells, was sufﬁcient to rescue the post-embryonic drug
hypersensitivity and bacterial resistance phenotypes of the hypo-
morphic allele lj22 (Figs. 6B, C). This supports the hypothesis that all of
the post-embryonic phenotypes, including drug sensitivity, are
secondary to the epidermal structural defect.
Discussion
BUS-8 is a glycosyltransferase required for embryonic ventral enclosure
and later for post-embryonic epidermal integrity
In this paper, we describe the developmental and molecular
analysis of the C. elegans gene bus-8, which has multiple and essential
roles in epidermal morphogenesis. Complete loss of bus-8 function
leads to embryonic arrest during ventral enclosure, the process where
the embryo is covered by a layer of epidermal cells. We have cloned
bus-8 and show that it encodes a glycosyltransferase, T23F2.1,
homologous to mannosyltransferases involved in protein N-glycosy-
lation. Despite the well known roles of proteoglycans in many
processes (Häcker et al., 2005), glycobiology has been comparatively
neglected by developmental biologists. This is unfortunate, as
glycosyltransferases such as Fringe (which modiﬁes Notch) play
crucial roles in development (Bruckner et al., 2002; Sasamura et al.,
2003; Wang et al., 2005). Furthermore, glycosyltransferases are
attractive targets for drugs, and several pharmaceuticals targeting
glycosylation have now reached the clinic (Butters et al., 2005; Dwek
et al., 2002). Only a small fraction of genes are ‘druggable’ —
pharmaceutically-accessible targets (Hopkins and Groom, 2002;
Russ and Lampel, 2005). Therefore understanding the roles of
glycosylation in the development of model organisms, and then in
human developmental disorders, has therapeutic potential that
studies of less druggable protein families lack.
BUS-8 and ephrin signalling
There is an obvious similarity between the ventral neuroblast
disorganisation and embryonic arrest phenotypes seen in bus-8(null)
mutants, and those phenotypes seen with mutations in the C. elegans
Eph vab-1 and ephrin vab-2. We showed that the weak bus-8 allele
e2887 shows synergistic embryonic lethality when combined with
weak alleles of vab-1, vab-2 and efn-4, implying that the genes work
together to mediate ventral organisation and enclosure. Although
there is only a single C. elegans Eph, in vertebrates the Eph receptors
are the largest subfamily of receptor tyrosine kinases. Together with
their ligands, the ephrins, they play important and much studied roles
in development. Eph receptor tyrosine kinases (RTKs) are involved in
axon guidance (Dickson, 2002), angiogenesis (Zhang and Hughes,
2006), regulation of cell adhesion andmigration (Pasquale, 2005), and
control of cell proliferation (Holmberg et al., 2006).
How could a glycosyltransferase inﬂuence ephrin signalling and
cell migration? The simplest explanation, that ephrin glycosylation
could promote Eph/ephrin oligomerisation, has received considerable
theoretical support from structural biologists (Himanen and Nikolov,
2003), but has not been experimentally addressed hitherto. However,
when we mutated a conserved glycosylation site in vab-2 that was
proposed to be important for Eph/ephrin oligomerisation, the N31Q
construct was still able to rescue a vab-2(null)mutant or a vab-2(null)
efn-4(null) double mutant.
Furthermore, we found that BUS-8 acts non-cell autonomously
during embryogenesis, as BUS-8 supplied by either neuronal or
epidermal promoters can rescue the embryonic lethal phenotype of
bus-8(null) mutants. This contrasts with the Eph/ephrins, which areexpressed in, and required in, the neuroblasts and not the migrating
epidermal cells (Chin-Sang et al., 1999; George et al., 1998). The
question of the mechanistic basis of the interaction between BUS-8
and Eph/ephrins is therefore interesting. Firstly, glycosylation of an
Eph/ephrin regulator could be functionally important. The weak
alleles of bus-8 such as e2887 provide the tools to identify this
potential regulator by an enhancer screen. We note that functionally
important glycosylation of a secreted cell migration regulator has been
demonstrated in another context: glycosylation of the metallopro-
tease MIG-17 is required for distal tip cell migration in C. elegans
gonadogenesis (Kubota et al., 2006). Alternatively, the extracellular
matrix (there is no cuticle at this stage of nematode embryogenesis)
environment might play a permissive role in allowing ephrin-
mediated neuroblasts movement and organisation. For example,
glycosylation of the extracellular matrix protein laminin is required
for its ability to support cell spreading in vitro (Runyan et al., 1988),
and in zebraﬁsh, depletion of β1,4-galactosyltransferase 1 leads to
improper laminin glycosylation, correlated with defects in convergent
extension during gastrulation (Machingo et al., 2006).
The LAR-like receptor phosphatase PTP-3 (Harrington et al., 2002)
and the semaphorin MAB-20 (Roy et al., 2000) as well as syndecan
proteins (Hudson et al., 2006) have also been found to contribute to
ventral enclosure, and it is conceivable that some of these molecules
might be subject to BUS-8-mediated glycosylation and regulation.
However, the strength and penetrance of the bus-8 mutant pheno-
types makes an involvement with ephrin signalling more likely.
An interesting parallel is with the Drosophila glycosyltransferases
Brainiac and Egghead, and their C. elegans homologues BRE-5 and
BRE-3, which act non-cell autonomously to promote activation of
Notch/LIN-12 (Goode et al., 1996; Katic et al., 2005). The BRE proteins
produce a glycosphingolipid which is exploited as a receptor by a Bt
toxin (Grifﬁtts et al., 2005). This, together with the BUS-8/Eph
interaction, highlights ﬁrstly that glycosylation is a widespread
regulator of multicellular signalling pathways; and secondly that the
evolution of developmental systems and selection driven by interac-
tions with pathogens are interlinked (discussed further below).
bus-8 mutants as tools for small molecule screening
C. elegans is of growing interest as a system for screening drug
candidates on a large scale, and for chemical genomics (Jones et al.,
2005). Two small scale proof-of-principle screens have been com-
pleted and more are underway (Ellerbrock et al., 2004; Gaud et al.,
2004). Notably, nemadipine-A, an inhibitor of C. elegans and
vertebrate L-type calcium channels has been identiﬁed (Kwok et al.,
2006). One problem with these studies is the cost of screening large
chemical libraries at physiologically active concentrations. Secondly,
the nematode cuticle and epidermis present a signiﬁcant barrier to
small molecule diffusion. This means that potential screening hits
could be missed due to inability to reach their target (Segalat, 2006).
Indeed, the efﬁcacy of nemadipine-A in C. elegans, but not L-type
calcium channel antagonists with similar structures, does not reﬂect
increased potency against vertebrate ion channels. Instead, nemadi-
pine-A is effective in C. elegans because it, unlike related molecules, is
able to accumulate in theworm (Kwok et al., 2006). Theweaker alleles
of bus-8 are hypersensitive to drugs, of a variety of structures, but do
not have obvious phenotypes outside the epidermis. The use of these
bus-8 alleles may facilitate small molecule screens by allowing the use
of lower concentrations of drugs, and by ameliorating the bias against
molecules that, though potentially active in vertebrates, cannot pass
through the nematode cuticle.
BUS-8 and infection
Weak bus-8mutants are resistant to infection byM. nematophilum
because the bacterium is unable to adhere to the cuticle (Gravato-
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coat is abnormal in bus-8 mutants, presumably leading to loss of a
receptor for M. nematophilum. This can be explained by two
mechanisms: ﬁrstly, BUS-8 may, amongst its other roles, produce a
surface-exposed glycan that is a receptor for M. nematophilum; or
secondly, the general epidermal defect seen in bus-8 mutants may
lead to a more pleiotropic defect in cuticle and surface coat synthesis.
These two hypotheses cannot at this point be formally resolved;
however the observation that bus-8(e2698) is resistant to infection,
but is otherwise phenotypically largely normal, favours the ﬁrst
explanation. Moreover, viable mutants of bus-8 are able to support
normal bioﬁlm formation by Yersinia bacteria (Creg Darby, personal
communication), indicating that the putative Yersinia receptor is not
affected, which also favours the ﬁrst explanation. That bus-8 plays
multiple and essential roles in development, but also produces a
receptor for a pathogen, is interesting in terms of the evolution of
host-pathogen interactions. Why does a host continue to express a
receptor that can be exploited by a pathogen? It seems that, in the case
of bus-8, the gene is required for a range of essential functions during
development, so cannot be easily lost or modiﬁed during evolution.
Other C. elegans genes required forM. nematophilum infection, such as
srf-3, are not absolutely required for viability in the laboratory.
However they display a variety of defects including increased cuticle
permeability, which suggests that they may be signiﬁcantly deleter-
ious in the natural environment of C. elegans (Gravato-Nobre et al.,
2005; Hoﬂich et al., 2004). These ‘host-associated patterns’ enable
pathogens to continue to infect their host. This is similar to the way
that ‘pathogen-associated molecular patterns,’ which allow recogni-
tion by the innate immune system, cannot be lost by pathogens as
they involve complex and essential processes such as cell-wall
biosynthesis (Janeway, 1989).
In summary, we conclude that the glycosyltransferase BUS-8 has
distinct essential roles in development. In the embryo, it acts together
with the Eph receptor VAB-1 to mediate ventral enclosure during
epidermal morphogenesis. Post-embryonically, it is required for
epidermal and cuticle integrity. This work adds to our understanding
of the importance of post-translational modiﬁcations such as
glycosylation for cell–cell signalling and organisation during the
development of multicellular organisms.
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